Skip to main content

CapForce Inc.

CFOR
Exchange
OTC
Industry
Services-Medical Laboratories
SEC CIK
0001293818

No open-market purchases or sales by CapForce Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Q4 2022 vs. Q3 2022

How the institutions holding CapForce Inc. changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of CFOR: Q3 2022 compared with Q4 2022
MeasureQ3 2022Q4 2022Change
Holders2326+3
Shares8.79M2.14M−6.64M (−75.6%)
Value$2.52M$521.8K−$1.99M (−79.3%)

New holders (8)

Institutions that held CapForce Inc. at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to CFOR in Q4 2022
InstitutionSharesValue% of portfolio
FNY Investment Advisers, LLC82,500$232.0K0.33%
HRT Financial LP191,437$26.0K0.00%
Ergoteles LLC128,748$18.2K0.00%
Goldman Sachs Group Inc20,638$2.91K0.00%
Two Sigma Securities, LLC19,986$2.82K0.00%
Millennium Management LLC11,304$2.00K0.00%
Morgan Stanley7,010$9880.00%
FMR LLC1,000$1410.00%

Sold out (5)

Institutions that held CapForce Inc. at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of CFOR in Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
Armistice Capital, LLC5,300,000$1.52M
Arete Wealth Advisors, LLC250,000$72.0K
Citadel Advisors LLC100,773$29.0K
Allen Capital Group, LLC30,000$9.00K
Valley National Advisers Inc500$0